Bausch + Lomb - Comment

Document ID: FDA-2012-N-0892-0004
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: May 31 2013, at 12:00 AM Eastern Daylight Time
Date Posted: May 31 2013, at 12:00 AM Eastern Standard Time
Comment Start Date: May 14 2013, at 12:00 AM Eastern Standard Time
Comment Due Date: June 13 2013, at 11:59 PM Eastern Standard Time
Tracking Number: 1jx-85mx-ujkj
View Document:

This is comment on Notice

See attached file(s)

Title:
Bausch and Lomb Comment FDA2004D-0042 Recommend Brief Sum-Comp Scores 31May2013

View Attachment:

Total: 2

Bausch + Lomb - Comment
Public Submission Posted: 05/31/2013 ID: FDA-2012-N-0892-0004

Comment Period Closed
Jun 13,2013 11:59 PM ET

Novartis - Comment
Public Submission Posted: 06/17/2013 ID: FDA-2012-N-0892-0005

Comment Period Closed
Jun 13,2013 11:59 PM ET